For DDX10 there is one paper [85] which co-cites DDX10 and one of its 11 predicted targets, TNFSF14, in a study of changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition in breast cancer cells. Here, DDX10 is linked to breast carcinoma.